In addition to his role as Entrepreneur-in-Residence at Versant, Lloyd is president and CEO of portfolio company Repare Therapeutics. Lloyd has served on several public and private Boards in the U.S. and Canada, and in 2013 he was honored as the Financial Times’ Outstanding Director of the Year for public corporations.
From 2010 to 2016 Lloyd was a Managing Partner with Persistence Capital Partners, Canada’s leading healthcare private equity investor. Previously he was a consultant with McKinsey & Company, and a co-founder and CEO of several successful biotechnology start-ups including Advanced Bioconcept and Caprion Pharmaceuticals/Caprion Proteomics. Lloyd holds a BA in politics from Brandeis University and an MBA from Harvard Business School.